• poolbeg pharma plc announces results for the year ended 31 december 2023 ACCESS Newswire Mon, 27 Jan 2025 07:16:41 GMT
• Cathal Friel’s Poolbeg Pharma plunges on merger talks that would see listing move to Nasdaq The Irish Independent Thu, 02 Jan 2025 08:00:00 GMT
• novelion's aegerion pharmaceuticals enters into licensing agreement with amryt pharma Reuters Thu, 05 Dec 2024 08:00:00 GMT
• acromegaly market forecasted to surge in coming years, 2024-2034 analysis by delveinsight | amryt pharma, chiasma, recordati, nova... The Globe and Mail Tue, 12 Nov 2024 08:00:00 GMT
• amryt pharma (lon:amyt) share price crosses above 50 day moving average – time to sell? Defense World Sat, 05 Oct 2024 10:09:02 GMT
• blocktrade - amryt pharma says placing to raise eur 15.0 million Reuters.com Sat, 21 Sep 2024 07:00:00 GMT
• amryt pharma (lon:amyt) share price crosses above 50-day moving average of $143.00 Defense World Fri, 20 Sep 2024 02:50:42 GMT
• poolbeg pharma plc (aim:polb) interim results for the six months to 30 june 2024 Share Talk Wed, 18 Sep 2024 07:00:00 GMT
• amryt pharma (lon:amyt) share price crosses below 50-day moving average of $143.00 Defense World Fri, 06 Sep 2024 09:25:50 GMT
• epidermolysis bullosa market growth to accelerate in forecast openPR Tue, 03 Sep 2024 07:00:00 GMT
• poolbeg pharma (aim:polb) to present at the h.c. wainwright 26th annual global investment conference Share Talk Tue, 27 Aug 2024 06:28:16 GMT
• amryt pharma (lon:amyt) shares pass below 50-day moving average of $143.00 Defense World Fri, 23 Aug 2024 10:27:12 GMT
• amryt pharma (lon:amyt) stock price passes below fifty day moving average of $143.00 Defense World Thu, 15 Aug 2024 10:25:14 GMT
• ‘the biggest companies in the world copied somebody else’ – leadership interview with cathal friel Business & Finance Thu, 15 Aug 2024 07:00:00 GMT
• amryt pharma (lon:amyt) stock passes above 50-day moving average of $143.00 Defense World Sat, 03 Aug 2024 22:00:21 GMT
• amryt pharma (lon:amyt) shares cross below 50 day moving average of $143.00 Defense World Fri, 26 Jul 2024 09:38:49 GMT
• poolbeg pharma plc – voluntary delisting from otcqb market Share Talk Fri, 26 Jul 2024 07:00:00 GMT
• amryt pharma (lon:amyt) share price passes below 50-day moving average of $143.00 Defense World Wed, 17 Jul 2024 09:48:32 GMT
• amryt pharma (lon:amyt) stock price passes below 50 day moving average of $143.00 Defense World Thu, 04 Jul 2024 18:13:07 GMT
• poolbeg pharma plc announces change of registered address AccessWire Tue, 02 Jul 2024 07:00:00 GMT
• amryt pharma plc sponsored adr (amyt) reports q3 loss, lags revenue estimates Yahoo New Zealand News Thu, 27 Jun 2024 05:33:00 GMT
• amryt pharma signs distribution deal for romania, bulgaria with romastru trading SeeNews Thu, 27 Jun 2024 03:06:18 GMT
• amryt pharma plc (lon:amyt): when will it breakeven? Yahoo News Australia Tue, 25 Jun 2024 20:33:52 GMT
• amryt pharma plc sponsored adr (amyt) surges 7.5%: is this an indication of further gains? Yahoo New Zealand News Fri, 21 Jun 2024 16:55:41 GMT
• Moncef Slaoui joins board at mRNA biotech; Gamida Cell retools with ex-Amryt CEO at the helm Endpoints News Fri, 21 Jun 2024 07:00:00 GMT
• Gamida Cell Announces New Leadership Under Ownership of Highbridge Capital Management Business Wire Tue, 18 Jun 2024 07:00:00 GMT
• amryt pharma (lon:amyt) stock crosses below 50-day moving average of $143.00 Defense World Sat, 15 Jun 2024 19:37:36 GMT
• amryt pharma (lon:amyt) stock passes above 50 day moving average of $143.00 Defense World Sat, 01 Jun 2024 09:14:47 GMT
• amryt pharma (lon:amyt) shares cross below 50-day moving average of $143.00 Defense World Fri, 24 May 2024 14:09:50 GMT
• amryt pharma holdings (lon:amyt) price about to hit new 52-week high Yahoo News UK Thu, 16 May 2024 07:46:12 GMT
• amryt pharma holdings (lon:amyt) price about to hit new 52-week high Yahoo News UK Sun, 12 May 2024 13:51:19 GMT
• amryt pharma (lon:amyt) shares pass below 50 day moving average of $143.00 Defense World Sat, 11 May 2024 07:00:00 GMT
• amryt (amyt) mycapssa gets orphan drug tag for carcinoid syndrome Yahoo Lifestyle UK Mon, 06 May 2024 19:02:48 GMT
• amryt pharma plc sponsored adr (amyt) surges 5.5%: is this an indication of further gains? Yahoo Canada Shine On Mon, 06 May 2024 01:06:00 GMT
• amryt (amyt) nda for skin disorder drug gets priority review Yahoo Lifestyle UK Sun, 05 May 2024 01:40:25 GMT
• why amryt pharma (amyt) might surprise this earnings season Yahoo Singapore News Fri, 03 May 2024 13:56:14 GMT
• why amryt pharma (amyt) might surprise this earnings season Yahoo Singapore News Thu, 02 May 2024 14:22:16 GMT
• amryt (amyt) mycapssa gets orphan drug tag for carcinoid syndrome Yahoo Lifestyle UK Tue, 30 Apr 2024 11:59:14 GMT
• poolbeg pharma plc announces results for the year ended 31 december 2023 Yahoo Finance Tue, 30 Apr 2024 07:00:00 GMT
• poolbeg pharma plc announces appointment of joint broker Yahoo Canada Finance Tue, 30 Apr 2024 06:02:00 GMT
• poolbeg pharma plc announces appointment of joint broker Yahoo Canada Finance Mon, 29 Apr 2024 07:00:00 GMT
• chiesi group's 2023 revenue surpasses €3 billion European Pharmaceutical Manufacturer Mon, 22 Apr 2024 07:00:00 GMT
• amryt pharma (lon:amyt) share price crosses below 50-day moving average of $143.00 Defense World Wed, 17 Apr 2024 09:07:26 GMT
• chiasma stock shoots up on being acquired by amryt pharma in all stock deal AOL Mon, 15 Apr 2024 22:26:45 GMT
• amryt pharma (lon:amyt) stock price passes below 50 day moving average of $143.00 Defense World Sat, 30 Mar 2024 07:00:00 GMT
• Serial entrepreneur Cathal Friel predicts the return of IPOs to Ireland businessplus.ie Fri, 29 Mar 2024 07:00:00 GMT
• cathal friel announces plans to list 'egt' to fund green transition portfolio Irish Independent Mon, 18 Mar 2024 07:00:00 GMT
• cathal friel announces plans to list ‘egt’ to fund green transition portfolio Irish Independent Mon, 18 Mar 2024 07:00:00 GMT
• amryt pharma (lon:amyt) stock price passes below 50 day moving average of $143.00 Defense World Fri, 15 Mar 2024 10:57:49 GMT
• amryt pharma (lon:amyt) stock price passes below 50-day moving average of $143.00 AmericanBankingNEWS Sat, 02 Mar 2024 09:39:51 GMT
• poolbeg pharma plc - director share purchase -february 23, 2024 at 07:52 am est Marketscreener.com Fri, 23 Feb 2024 08:00:00 GMT
• poolbeg pharma plc announces director/pdmr shareholding Yahoo Finance Thu, 22 Feb 2024 08:00:00 GMT
• poolbeg pharma plc announces director/pdmr shareholding Yahoo Finance Wed, 21 Feb 2024 08:00:00 GMT
• poolbeg pharma plc - director share purchase -february 20, 2024 at 08:33 am est Marketscreener.com Tue, 20 Feb 2024 13:33:20 GMT
• poolbeg pharma chairman tops up with share purchase Proactive Investors UK Mon, 19 Feb 2024 08:00:00 GMT
• cathal friel steps into the executive chair role at poolbeg pharma as leadership team beefed up Irish Independent Fri, 16 Feb 2024 02:30:00 GMT
• Poolbeg Pharma shares jump on appointment of Cathal Friel as Executive Chairman Vox Markets Thu, 15 Feb 2024 08:00:00 GMT
• cathal friel steps into the executive chair role at poolbeg pharma as leadership team beefed up The Irish Independent Thu, 15 Feb 2024 08:00:00 GMT
• poolbeg pharma’s cathal friel assumes role of executive chairman DirectorsTalk Interviews Thu, 15 Feb 2024 08:00:00 GMT
• poolbeg pharma plc announces board role change and launch of eip ACCESS Newswire Thu, 15 Feb 2024 08:00:00 GMT
• poolbeg pharma chairman to take an executive role with fast-growing drugs group Proactive Investors UK Thu, 15 Feb 2024 08:00:00 GMT
• poolbeg pharma names executive chairman | the pharmaletter The Pharma Letter Thu, 15 Feb 2024 08:00:00 GMT
• poolbeg pharma's cathal friel assumes role of executive chairman DirectorsTalk Interviews Thu, 15 Feb 2024 08:00:00 GMT
• poolbeg pharma plc appoints cathal friel as executive chairman Marketscreener.com Thu, 15 Feb 2024 07:00:00 GMT
• poolbeg pharma plc announces board role change and launch of eip Yahoo Finance Wed, 14 Feb 2024 08:00:00 GMT
• filsuvez's european approval adds growth driver for amryt pharma AOL Wed, 14 Feb 2024 01:11:04 GMT
• poolbeg claims polb 001 could be at $10 billion market opportunity The Pharma Letter Mon, 12 Feb 2024 12:06:49 GMT
• poolbeg pharma plc announces market opportunity for polb 001 for crs ACCESS Newswire Mon, 12 Feb 2024 08:00:00 GMT
• poolbeg pharma plc announces market opportunity for polb 001 for crs Yahoo Finance Sun, 11 Feb 2024 08:00:00 GMT
• poolbeg pharma clo reveals what he's "looking to get his teeth into" in 2024 Proactive Investors UK Tue, 23 Jan 2024 08:00:00 GMT
• €1.5bn irish life sciences m&a market powered by amryt pharma deal Business Plus Mon, 22 Jan 2024 08:00:00 GMT
• life sciences a rare bright spot in muted irish m&a activity last year - ey The Irish Times Mon, 22 Jan 2024 08:00:00 GMT
• m&a deals among irish life science firms soar 600% in value Business Post Mon, 22 Jan 2024 08:00:00 GMT
• life sciences mergers and acquisitions leap in value to €1.5bn The Irish Independent Sun, 21 Jan 2024 08:00:00 GMT
• business person of the month december: cathal friel, chair and co-founder of hvivo, steers continued growth for ... Business & Finance Mon, 08 Jan 2024 08:00:00 GMT
• Chiesi’s $1.25B Amryt Buy Pays Off with FDA Approval of Filsuvez BioSpace Wed, 20 Dec 2023 08:00:00 GMT
• After Amryt buyout, Chiesi scores with FDA nod for rare skin disease treatment Filsuvez Fierce Pharma Wed, 20 Dec 2023 08:00:00 GMT
• Chiesi Rare Skin Disease Drug Acquired in Billion Dollar Deal Wins FDA Approval MedCity News Tue, 19 Dec 2023 08:00:00 GMT
• fda approves topical for rare skin disorder Managed Healthcare Executive Tue, 19 Dec 2023 08:00:00 GMT
• poolbeg pharma plc announces polb 001 data presented at ash WGHP FOX8 Greensboro Mon, 11 Dec 2023 07:00:00 GMT
• somatostatin receptor type 2 market examining share and size ... Artrocker Mon, 04 Dec 2023 13:17:09 GMT
• medicamentos huérfanos mercado a alcanzar $3199.3 billion a ... blogdenuevayork.es Mon, 04 Dec 2023 08:57:21 GMT
• poolbeg pharma could reach €1bn valuation, says chief executive Business Post Mon, 04 Dec 2023 08:00:00 GMT
• orphan drugs market expected to reach usd 435.68 billion by 2030 | cagr of 11.8% WhaTech Technology and Markets News Fri, 01 Dec 2023 10:32:54 GMT
• poolbeg pharma non-exec steps down from board Proactive Investors UK Thu, 30 Nov 2023 08:00:00 GMT
• chiesi in-licenses dpp1 inhibitor from haisco pharma The Pharma Letter Mon, 20 Nov 2023 08:00:00 GMT
• chiesi partners with haisco to commercialise bronchiectasis drug Pharmaceutical Technology Mon, 20 Nov 2023 08:00:00 GMT
• poolbeg pharma plc announces immunomodulator ii patent ... Yahoo Finance Mon, 20 Nov 2023 08:00:00 GMT
• new and notable appointments at acca ireland, mymortgages.ie ... Business & Finance Fri, 17 Nov 2023 08:00:00 GMT
• poolbeg pharma polb 001 lps challenge trial data to be ... DirectorsTalk Interviews Thu, 16 Nov 2023 08:00:00 GMT
• chiesi farmaceutici punta a chiudere il ’23 con un fatturato di circa 3 ... VeneziePost Tue, 14 Nov 2023 17:06:00 GMT
• amryt trio join poolbeg leadership team | pharmaceutical | the pharmaletter | the pharmaletter The Pharma Letter Fri, 10 Nov 2023 08:00:00 GMT
• gene editor metagenomi adds c-suite execs—chutes & ladders FierceBiotech Fri, 10 Nov 2023 08:00:00 GMT
• poolbeg pharma beefs up leadership; brings key players from successful amryt pharma team Proactive financial news Thu, 09 Nov 2023 08:00:00 GMT
• poolbeg pharma appoints 3 former amryt pharma executives to leadership team, shares gain Vox Markets Thu, 09 Nov 2023 08:00:00 GMT
• poolbeg pharma appoints senior members of former amryt pharma leadership team DirectorsTalk Interviews Thu, 09 Nov 2023 08:00:00 GMT
• former amryt pharma leadership team to join poolbeg pharma Business Plus Thu, 09 Nov 2023 08:00:00 GMT
• in brief: poolbeg pharma appoints former amryt executives to team Morningstar Thu, 09 Nov 2023 08:00:00 GMT
• proactive news headlines: galliford try, poolbeg, genel, chill and ... Proactive Investors USA Thu, 09 Nov 2023 08:00:00 GMT
• poolbeg pharma plc annonce des nominations à des postes de ... Zonebourse.com Thu, 09 Nov 2023 07:00:00 GMT
• orphan drugs industry size, share, trend | complete analysis | amryt ... Argyle Report Wed, 08 Nov 2023 09:43:16 GMT
• poolbeg pharma polb 001 data to be presented at american ... DirectorsTalk Interviews Fri, 03 Nov 2023 07:00:00 GMT
• le marché des médicaments orphelins pour adultes devrait ... jcsr.ch Fri, 03 Nov 2023 04:49:53 GMT
• orphan drugs market expected to reach $435.68 billion by 2030 ... PharmiWeb.com Tue, 31 Oct 2023 07:00:00 GMT
• orphan drugs market is projected to gain $4,35,686.3 million by ... Yahoo Finance Mon, 23 Oct 2023 07:00:00 GMT
• marketing firsts due as amryt's filsuvez and roche's lunsumio win eu nod pink.citeline.com Mon, 09 Oct 2023 17:49:24 GMT
• amryt due for oral explanation at ema for epidermolysis bullosa gel filsuvez Pink Sheet Fri, 06 Oct 2023 10:46:57 GMT
• in brief: yellow cake takes kazatomprom triuranium octoxide ... Morningstar Mon, 02 Oct 2023 07:00:00 GMT
• amryt's filsuvez wins english funding for butterfly skin disease, sanofi's dupixent rejected in new indication Pink Sheet Wed, 20 Sep 2023 06:52:32 GMT
• online hyperlocal services market growth, competitive landscape ... Digital Journal Thu, 14 Sep 2023 07:00:00 GMT
• malattie rare: fondazione telethon prima charity al mondo ... Osservatorio Malattie Rare Tue, 12 Sep 2023 07:00:00 GMT
• il big dei tappi crealis (ex enoflex), controllato da cobepa, incassa ... BeBeez Fri, 08 Sep 2023 15:18:56 GMT
• poolbeg pharma a.i. unlocking the power of unique human ... DirectorsTalk Interviews Mon, 04 Sep 2023 07:00:00 GMT
• birch tree extract offers hope for rare skin disorder • the medical ... The Medical Republic Mon, 04 Sep 2023 07:00:00 GMT
• amryt announces positive long-term safety and efficacy data confirming the role for mycapssa® (oral octreotide) in the management ... Barchart.com Fri, 01 Sep 2023 11:06:23 GMT
• european green metals: unlocking europe's critical minerals with ... Innovation News Network Tue, 22 Aug 2023 08:25:43 GMT
Amryt Pharma plc(NASDAQ:AMYT) 
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the compl...
Website: https://www.amrytpharma.com
Founded: 2004
Full Time Employees: 289
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Share this website to your friends